Oncology / Ibrutinib / Pitch / Launch
Now approved ad concept.
The molecules represented the beehive design for branding
Launch concept / we used the bee hive to drive home that we attacked B cells in mantle cell Lymphoma
Killer B was one of fthe pitch concepts that helped win the Ibrutinib business
Follow up patient ad concepts and launch materials / iVIS / mobile
CONCEPT : The dove drawn over the hand grenade helps tell the story or a new treatment for patients with previously treated Mantle Cell Lymphoma (MCL). It was an oral, clinical shown to improve symptoms or survival. It had a gentler side effect profile, which inspired the peace over war motif.
CONCEPT : The art was to have a Bansky look and feel
IMBRUVICA (Ibrutinib) is a kinase inhibitor indicated for the treatment of adult patients with mantle cell lymphoma (MCL) who have recieved at least prior therapy.
-
Role Lead ACD for developing concepts and preparing all materials for pitch. After winning the pitch was responsible overseeing launch.
Up Next: